Treatment of Nasopharyngeal Carcinoma Cells with the Histone-Deacetylase Inhibitor Abexinostat: Cooperative Effects with Cis-platin and Radiotherapy on Patient-Derived Xenografts

EBV-related nasopharyngeal carcinomas (NPCs) still raise serious therapeutic problems. The therapeutic potential of the histone-deacetylase (HDAC) inhibitor Abexinostat was investigated using 5 preclinical NPC models including 2 patient-derived xenografts (C15 and C17). The cytotoxicity of Abexinost...

Descripción completa

Detalles Bibliográficos
Autores principales: Gressette, Mélanie, Vérillaud, Benjamin, Jimenez-Pailhès, Anne-Sophie, Lelièvre, Hélène, Lo, Kwok-Wai, Ferrand, François-Régis, Gattolliat, Charles-Henry, Jacquet-Bescond, Anne, Kraus-Berthier, Laurence, Depil, Stéphane, Busson, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3949989/
https://www.ncbi.nlm.nih.gov/pubmed/24618637
http://dx.doi.org/10.1371/journal.pone.0091325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3949989/
https://www.ncbi.nlm.nih.gov/pubmed/24618637
http://dx.doi.org/10.1371/journal.pone.0091325

Ejemplares similares